Skip to main content

Table 2 Prediction of changes in CTX and P1NP using a general linear model

From: Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients

Variables

CTX, pg/ml (330.759 ± 166.5)

P1NP, pg/ml (160.703 ± 139.9)

P-valuea

Partial Eta squared

P-valuea

Partial Eta squared

EPO

< 0.0001

0.152

0.024

0.064

Estrogen or testosterone

0.029

0.060

0.816

0.001

OPG

0.335

0.012

0.009

0.083

RANKL

0.017

0.071

< 0.0001

0.194

  1. CTX carboxy terminal collagen cross links, P1NP N-terminal propeptide of type 1 collagen, EPO erythropoietin, OPG osteoprotegerin, RANKL receptor activator of NF-kappaB ligand
  2. aP-values were calculated by a general linear model with CTX and P1NP as outcome variables